ENTRADA

Serial Number 97330161
Registration 8096243
700

Registration Progress

Application Filed
Mar 25, 2022
Under Examination
Approved for Publication
Published for Opposition
Jan 24, 2023
Registered
Jan 6, 2026

Trademark Image

ENTRADA

Basic Information

Serial Number
97330161
Registration Number
8096243
Filing Date
March 25, 2022
Registration Date
January 6, 2026
Published for Opposition
January 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 6, 2026
Registration
Registered
Classes
042

Rights Holder

Entrada Therapeutics, Inc.

03
Address
One Design Center Pl, Suite 17-500
Boston, MA 02210

Ownership History

Entrada Therapeutics, Inc.

Original Applicant
03
Boston, MA

Entrada Therapeutics, Inc.

Owner at Publication
03
Boston, MA

Entrada Therapeutics, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Stephanie H. Bald

USPTO Deadlines

Next Deadline
2179 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 06, 2032
Grace Period Ends
July 06, 2032

Application History

50 events
Date Code Type Description Documents
Jan 6, 2026 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 6, 2026 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 12, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 12, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 12, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 12, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2025 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2025 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN Loading...
Sep 22, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 22, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 26, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2025 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Feb 28, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 28, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 28, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 27, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 20, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 12, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Feb 12, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 13, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 13, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Nov 13, 2024 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Nov 12, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 11, 2024 IUAF S USE AMENDMENT FILED Loading...
Nov 12, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 11, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 12, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 23, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development services
First Use Anywhere: 20230200
First Use in Commerce: 20230200

Additional Information

Translation
The English translation of "ENTRADA" in the mark is "ENTRANCE".

Classification

International Classes
042